RxDoctor Payments Data

Christopher Homsy, MD

Plastic and Reconstructive Surgery · Boston, MANPI 1861747826

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $10,658 of the $12,174 with a category attached, or 87.5%. It is spread thinly across 33 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations.

$12,174in general payments, 2019–2025

Across 132 payments — averaging $92.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dilon Technologies, Inc.$2K
  • Mentor Worldwide LLC$2K
  • Medical Device Business Services, Inc.$1K
  • Sientra, Inc.$789
  • Biom'up France SAS$759
  • Aroa Biosurgery Incorporated$751
  • plus $5K from 27 others

What the payments were for

  • Travel & lodging$1,1299%
  • Food & beverage$10,65888%
  • Education$2412%
  • Other$1471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,174 in reported general payments places this provider in the 85th percentile of 67 plastic and reconstructive surgery providers in Massachusetts.

See all plastic and reconstructive surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$53,910
Medicare patients
66
Services billed
164

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic and reconstructive surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →